The lab tests also showed that some antibodies have entirely lost their ability to neutralise Omicron at realistic dosages. "The bottom line is we have countermeasures to treat Omicron. That's good news," said study lead author Yoshihiro Kawaoka, from the University of Wisconsin-Madison in the US.
from Economic Times https://ift.tt/3fZ5msL
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The EUA will facilitate broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease, enabling access to remdesivi...
No comments:
Post a Comment